Regeneron Pharmaceuticals Inc. (REGN) announced recently that is investing $40 million, which will result in the creation of up to 100 jobs in East Greenbush facility in Rensselaer County, coupled with another 300 jobs at its Westchester County facility, both in New York. The new positions will be created primarily for research.

Regeneron increased its presence at the Landmark at Eastview campus in Tarrytown, New York, when the landlord BioMed Realty Trust Inc. (BMR), a real estate investment trust, entered into a new lease agreement with Regeneron for approximately 131,000 square feet of additional, newly-constructed laboratory and office space through 2023.

This is the third research facility for Regeneron in Tarrytown. The new lease was completed about a couple of months after BioMed and Regeneron opened two new buildings at the 116-acre campus. They were built by BioMed to serve as Regeneron’s corporate headquarters and research facility.

A tenant on the 116-acre campus since 1989, Regeneron occupies approximately 390,000 square feet after the third research building was completed.

The expansion related news comes on the heels of another positive development for the company. A few days ago Regeneron and Sanofi-Aventis (SNY) announced that the extension and expansion of their antibody collaboration program. The companies had initially entered into a collaboration agreement in 2007, which was scheduled to expire in 2012.

Under the extended agreement, Sanofi will increase its annual funding commitment by $60 million to $160 million from 2010. Moreover, the agreement will now extend through 2017 with Sanofi having the option to extend the program for an additional three years. The companies are looking to move four to five antibodies into clinical development every year.

Currently, we are Neutral on Regeneron.

Zacks Investment Research

1. (SNY) Sanofi-Aventis Expands Regeneron Pharmaceuticals AgreementSanofi-Aventis (SNY) recently extended and expanded its antibody collaboration with biopharmaceutical company, Regeneron Pharmaceuticals, Inc....
2. (KFT) Kraft to Construct New Research and Development CenterKraft Foods Inc. (KFT), a leading manufacturer and marketer of packaged food and grocery products...
3. ($SU) Suncor Energy to Expand Ethanol PlantSuncor Energy (SU) recently resumed the expansion of its St. Clair ethanol plant near Sarnia,...
4. (REGN) Regeneron Pharmaceuticals Enrolls for StudiesLast week, Regeneron Pharmaceuticals, Inc. (REGN) announced the completion of enrollment in two late stage...
5. (SNY) Sanofi-Aventis and Regeneron Pharmaceuticals Suffer Late-stage Pipeline SetbackOn Friday, Sanofi-Aventis (SNY) and collaboration partner, Regeneron Pharmaceuticals (REGN) suffered a pipeline setback with...
6. (WMB) Williams Companies to Expand Transco PipelineWilliams Companies Inc. (WMB) said on Wednesday that the Federal Energy Regulatory Commission (FERC) permitted...

Search Posts by Tag: BioMed Realty Trust Inc. | BMR | Regeneron Pharmaceuticals Inc | REGN | Sanofi-Aventis | SNY | Biotechnology | Healthcare

RSS Feeds by Tag: BioMed Realty Trust Inc. | BMR | Regeneron Pharmaceuticals Inc | REGN | Sanofi-Aventis | SNY | Biotechnology | Healthcare |

Other Posts by: vitalstocks | RSS Feed for this author